Genomics and multi-omics companies develop technologies, services and analytical platforms that help researchers and clinicians understand biological systems at the DNA, RNA, protein and cellular level. The field underpins advances in precision medicine, drug discovery, diagnostics, agriculture and biotechnology.
This category includes companies working on:
Browse 190 UK genomics and multi-omics companies below.
Clinical whole genome sequencing and reporting platform
StoreGene is a UCL spin-out providing a clinical genomic operating system that integrates whole genome sequencing with automated bioinformatics pipelines and genomic counselling services. Its platform generates clinical reports across cardiovascular genetics, hereditary cancer, pharmacogenomics, and nutrigenetics,…
Aquaculture selective breeding, genomics and genotyping services
Benchmark Genetics is an aquaculture biotechnology company developing improved farmed fish and shellfish stocks through selective breeding and genomics. It supplies genetically selected Atlantic salmon eggs and shrimp genetics and provides genotyping, breeding programme design, genomic selection and genetics services…
Long-read RNA sequencing platform for cancer biomarker discovery and diagnostics
Wobble Genomics is a Scottish biotechnology company developing long-read RNA sequencing technologies for biomarker discovery and cancer diagnostics. Its core platform combines a biochemical method to enrich rare and low-abundance full-length RNA transcripts, with a bioinformatics pipeline for novel transcript…
Precision medicine platform for patient recruitment and genetic testing
Sano Genetics is a London-based software company providing an end-to-end platform for patient recruitment, at-home genetic testing, and long-term participant engagement in precision medicine clinical trials and population genomics programmes. The platform integrates DNA testing logistics, medical history retrieval,…
Mitochondrial DNA liquid biopsy tests for cancer and disease detection
MDNA Life Sciences is a biotechnology company developing proprietary diagnostic tests based on mitochondrial DNA biomarkers. Its technology detects specific mitochondrial DNA deletions in blood and tissue samples as indicators of disease, enabling non-invasive testing for conditions that are difficult to diagnose.…
Next-generation sequencing and genomic analysis services
Novogene (UK) is a genomic services provider operating as the European hub of Novogene Corporation, one of the world's largest sequencing organisations. Based at Cambridge Science Park, the company offers a comprehensive range of next-generation sequencing services including whole genome, exome, RNA, single-cell,…
Causal cellular data and AI models for drug discovery
CellCodex is a biotechnology company that generates causal data from human cells to train predictive models for drug discovery. It programmes stem cells into pure, aged, disease-relevant cell types, perturbs them at genome scale with CRISPR and compounds, and reads the outcome in single cells. The company applies the…
Food and gut health bioscience research on Norwich Research Park
Quadram Institute Bioscience is a BBSRC-funded independent research organisation focused on the interactions between food, gut microbiota, and human health. Operating within the Quadram Institute, a partnership with the University of East Anglia, Norfolk and Norwich University Hospitals, and BBSRC, it conducts…
Molecular diagnostic PCR, dPCR and NGS kits for clinical laboratories
TRUPCR Europe develops and supplies molecular diagnostic kits and reagents for clinical and research laboratories. Its portfolio includes real-time PCR, digital PCR and next-generation sequencing assays for oncology, haematological malignancies, infectious diseases and antimicrobial resistance. Products also include…
AI epigenomics platform for neurodegenerative disease detection
Prima Mente is a biotechnology company developing large-scale biological foundation models to understand and detect neurodegenerative disease. The company generates proprietary multi-omic data including whole-epigenome sequencing, and trains transformer-based models on DNA methylation patterns in cell-free DNA to…
Research kits and services for RNA-binding protein analysis
Ascent RNA is an early-stage biotechnology company developing molecular biology tools and research services for analysing RNA and its interactions with proteins. Its proprietary methods are designed to help researchers identify RNA targets and characterise RNA-binding proteins, with planned laboratory kits and…
University genomics core facility for sequencing, single-cell and spatial analysis
The Imperial BRC Genomics Facility is a university core facility supporting translational genomics research. It provides next-generation sequencing, single-cell genomics, spatial transcriptomics and proteomics, alongside experimental design, library preparation and bioinformatics analysis. Its services are used to…
Specialist biomarker and bioanalytical CRO for clinical drug development
Synexa Life Sciences is a specialist contract research organisation providing biomarker and bioanalytical laboratory services to global biopharmaceutical companies. The company develops, validates, and delivers custom assays supporting clinical trials and translational studies, with expertise spanning LC-MS/MS…
Precision medicine platform matching cancer patients to optimal therapies
Pathway Bio is a precision oncology company developing a functional platform to predict treatment response in individual cancer patients. The platform combines multiomic tumour profiling, AI-driven modelling, and ex vivo microcancer technology to screen therapies against a biological avatar of the patient's own tumour…
Genomic risk prediction platform for preventive healthcare and drug discovery
Genomics is a data science company that uses large-scale human genetic data to power precision healthcare and drug discovery. Its proprietary platform links millions of genetic variants to thousands of biological measurements and disease outcomes, generating polygenic risk scores that enable earlier identification of…
Multi-omic sequencing and genomics services
Source Genomics is a contract genomics laboratory providing multi-omic sequencing and analytical services to pharmaceutical, biotechnology, and academic clients. Services span Sanger sequencing, next-generation sequencing, Oxford Nanopore long-read sequencing, spatial transcriptomics, optical genome mapping, Olink…
AI-driven target identification and drug discovery from omics data
Intelligent OMICS is a biotechnology company applying artificial intelligence and machine learning to drug discovery and diagnostics. Its proprietary platform analyses transcriptomic, genomic, and proteomic datasets to identify novel biological targets and disease drivers. The company offers fee-for-service target…
Molecular diagnostics, biomarker research and genomic analysis services
BioMarker Solutions is a diagnostics and research services company supporting biomarker discovery, validation and molecular testing. Its activities cover genomic analysis, oncology diagnostics, clinical trial support, digital pathology and laboratory information systems. The group offers NGSuite software for…
3D genomics platform for blood-based clinical diagnostics and precision medicine
Oxford BioDynamics develops blood-based diagnostic tests and precision medicine tools using its proprietary 3D genomics platform. The technology analyses chromosome conformation to identify epigenomic biomarkers linked to disease, prognosis and treatment response. Commercial products include tests for immune…
Cambridge cancer research institute advancing discovery and clinical translation
Cancer Research UK Cambridge Institute is a cancer research institute within the University of Cambridge, investigating tumour biology, early detection and treatment. Its research groups study cancer evolution, genomics and the tumour microenvironment, using imaging and computational approaches to improve diagnosis…